IN8bio (INAB) Institutional Ownership $2.39 +0.10 (+4.37%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$2.40 +0.00 (+0.21%) As of 10/3/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for IN8bio (NASDAQ:INAB)CurrentInstitutional OwnershipPercentage92.05%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$253.02MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$77.55M Get INAB Insider Trade Alerts Want to know when executives and insiders are buying or selling IN8bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data INAB Institutional Buying and Selling by Quarter IN8bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025Stonepine Capital Management LLC82,430$172K0.2%N/A2.720% 8/12/2025BIOS Capital Management LP286,664$599K0.8%-96.7%9.461% 8/12/2025Franklin Resources Inc.189,894$397K0.0%-96.7%6.267% 8/8/2025Geode Capital Management LLC18,820$39K0.0%-96.7%0.622% 7/29/2025AIGH Capital Management LLC149,895$313K0.1%-89.7%4.947% 5/16/2025Alyeska Investment Group L.P.2,079,575$345K0.0%-58.9%2.291% 5/6/2025AIGH Capital Management LLC1,450,000$241K0.1%-76.6%1.784% 5/2/2025Sigma Planning Corp700,680$116K0.0%-32.7%0.862% 2/18/2025BIOS Capital Management LP8,600,001$2.21M2.4%N/A11.865% 2/17/2025Alyeska Investment Group L.P.5,063,291$1.30M0.0%+1,064.5%6.986% Get the Latest News and Ratings for INAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IN8bio and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025683 Capital Management LLC750,000$193K0.0%-44.5%1.035% 2/14/2025Jane Street Group LLC115,919$30K0.0%+296.7%0.160% 2/12/2025Geode Capital Management LLC515,193$133K0.0%+56.5%0.711% 2/12/2025Franklin Resources Inc.5,696,202$1.47M0.0%N/A7.859% 2/12/2025AIGH Capital Management LLC6,191,865$1.59M0.5%+269.7%8.543% 2/10/2025BIOS Capital Management LP8,600,001$2.21M2.3%N/A11.865% 2/3/2025Sigma Planning Corp1,041,380$268K0.0%+22.3%1.437% 11/4/2024Sigma Planning Corp851,280$230K0.0%+42.0%1.819% 8/7/2024AIGH Capital Management LLC2,127,998$1.80M0.6%-26.0%4.823% 2/12/2024AIGH Capital Management LLC4,098,361$5.22M2.1%N/A12.811% 2/8/2024Texas Capital Bank Wealth Management Services Inc78,624$109K0.0%+85.2%0.246% 2/1/2024Sigma Planning Corp132,230$182K0.0%-53.6%0.413% 1/30/2024Voss Capital LLC341,209$471K0.0%-33.3%1.067% 11/13/2023Rock Creek Group LP151,314$157K0.0%+98.3%0.473% 10/19/2023Voss Capital LLC511,584$532K0.1%+11.7%1.619% 8/11/2023Overbrook Management Corp33,756$52K0.0%N/A0.113% 8/2/2023Sigma Planning Corp279,400$430K0.0%+37.0%0.939% 7/28/2023Voss Capital LLC457,876$705K0.1%+35.5%1.539% 5/8/2023Sigma Planning Corp203,900$265K0.0%+105.6%0.816% 2/13/2023Voss Capital LLC338,019$781K0.2%-10.0%1.380% 11/15/2022Precept Management LLC50,000$101K0.7%N/A0.204% 11/7/2022Warberg Asset Management LLC15,000$30K0.0%N/A0.080% 11/2/2022Voss Capital LLC375,570$759K0.2%-25.7%1.993% 10/28/2022Stonegate Investment Group LLC232,310$469K0.0%-12.8%1.233% 10/24/2022United Asset Strategies Inc.14,000$28K0.0%N/A0.074% 8/15/2022Nantahala Capital Management LLC148,801$359K0.0%-57.8%0.790% 8/13/2022Voss Capital LLC505,635$1.14M0.4%+95.2%2.684% 8/9/2022Stonegate Investment Group LLC266,500$602K0.0%N/A1.415% 5/11/2022Rock Creek Group LP86,032$299K0.0%+87.5%0.457% 4/20/2022Sigma Planning Corp97,750$326K0.0%+241.8%0.520% 2/11/2022Ensign Peak Advisors Inc70,028$307K0.0%N/A0.373% 2/10/2022HighTower Advisors LLC10,000$44K0.0%N/A0.053% 2/2/2022Sigma Planning Corp28,600$126K0.0%N/A0.153% 11/16/2021Voss Capital LLC80,727$555K0.2%N/A0.430% 11/16/2021Capital World Investors800,000$5.52M0.0%N/A4.266% 11/15/2021Tudor Investment Corp Et Al63,287$434K0.0%N/A0.337% 11/10/2021B. Riley Financial Inc.257,378$1.76M0.2%N/A1.372% (Data available from 1/1/2016 forward) INAB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INAB shares? During the previous two years, 12 institutional investors and hedge funds held shares of IN8bio. The most heavily invested institutionals were BIOS Capital Management LP ($599K), Voss Capital LLC ($471K), Franklin Resources Inc. ($397K), Alyeska Investment Group L.P. ($345K), AIGH Capital Management LLC ($313K), 683 Capital Management LLC ($193K), and Stonepine Capital Management LLC ($172K).Learn more on IN8bio's institutional investors. What percentage of IN8bio's stock is owned by institutional investors? 92.05% of IN8bio's stock is owned by institutional investors. Learn more on INAB's institutional investor holdings. Which institutional investors have been buying IN8bio's stock? Of the 11 institutional investors that purchased IN8bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($17.20M), AIGH Capital Management LLC ($8.62M), Franklin Resources Inc. ($5.70M), Alyeska Investment Group L.P. ($4.63M), Sigma Planning Corp ($441.70K), Geode Capital Management LLC ($185.92K), and Jane Street Group LLC ($86.70K). How much institutional buying is happening at IN8bio? Institutional investors have bought a total of 32,838,658 shares in the last 24 months. This purchase volume represents approximately $253.02M in transactions. Which of IN8bio's major shareholders have been selling company stock? The following institutional investors have sold IN8bio stock in the last 24 months: BIOS Capital Management LP ($8.31M), AIGH Capital Management LLC ($6.04M), Franklin Resources Inc. ($5.51M), Alyeska Investment Group L.P. ($2.98M), 683 Capital Management LLC ($600.30K), Geode Capital Management LLC ($549.81K), and Sigma Planning Corp ($340.70K). How much institutional selling is happening at IN8bio? Institutional investors have sold a total of 24,336,146 shares in the last 24 months. This volume of shares sold represents approximately $77.55M in transactions. Related Companies TLPH Institutional Ownership XLO Institutional Ownership GBIO Institutional Ownership JSPR Institutional Ownership DYAI Institutional Ownership VRCA Institutional Ownership XFOR Institutional Ownership BCAB Institutional Ownership ADAP Institutional Ownership ANVS Institutional Ownership This page (NASDAQ:INAB) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IN8bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IN8bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.